Dynabeads™ M-280 Sheep Anti-Mouse IgG
Dynabeads™ M-280 Sheep Anti-Mouse IgG
Invitrogen™

Dynabeads™ M-280 Sheep Anti-Mouse IgG

Dynabeads M-280ヒツジ抗マウスIgGは、アフィニティ精製ポリクローナルヒツジ抗マウスIgGをビーズ表面に共有結合させた2.8 μmの超常磁性ビーズです。これらのビーズは、マウスIgGとその標的タンパク質を簡単かつ効率的に結合するための固体担体として機能するように設計されています。均一、単分散、ノンポーラスのDynabeadsは、Ig結合詳細を見る
製品番号(カタログ番号)数量
11202D10 mL
11201D2 mL
製品番号(カタログ番号) 11202D
価格(JPY)
-
見積もりを依頼する
数量:
10 mL
Dynabeads M-280ヒツジ抗マウスIgGは、アフィニティ精製ポリクローナルヒツジ抗マウスIgGをビーズ表面に共有結合させた2.8 μmの超常磁性ビーズです。これらのビーズは、マウスIgGとその標的タンパク質を簡単かつ効率的に結合するための固体担体として機能するように設計されています。均一、単分散、ノンポーラスのDynabeadsは、Ig結合、タンパク質精製、サンドイッチ免疫測定法、免疫沈降(IP)、Co-IP、細胞や微生物の単離などのアプリケーションに最適です。ポリクローナルヒツジ抗体は、マウスIgG1、IgG2a、IgG2bと結合しますが、マウス IgG3およびIgMとの反応性は低くなります。ヒトの交差反応は最小限です。

•40分未満でタンパク質を単離
• ほとんどのマウスIgGサブクラスに結合
• シグナルノイズ比が高く、非特異的結合が非常に低い
• カラム、遠心分離、時間のかかる予備洗浄は不要
• KingFisher機器に適合する高い再現性とハイスループット

Dynabeadsの手動分離は迅速かつ簡単
標的分子を認識する一次抗体をサンプルに追加(間接的手法)するか、Dynabeads M-280ヒツジ抗マウスIgGにプレコートできます(直接的手法)。どの手法を使用する場合でも、Dynabeads M-280ヒツジ抗マウスIgGをサンプルと混合すると、ビーズはターゲットに結合します。DynaMagマグネットにサンプルを置くと、ビーズ結合ターゲットがサンプルの残りの部分から分離されます。その後、上清は吸引によって除去されます。標的分子は、従来の溶出法でビーズから溶出し、ウェスタンブロットや質量分析などのアプリケーションで使用したり、ビーズに付着したまま、さらに下流のアプリケーションで使用できます。

Dynabeadsの自動分離はスループットの向上とハンズオン時間の短縮に役立つ
複数のサンプルを並行して処理する場合は、サンプル数に比例して洗浄ステップ数とハンズオン時間が増加します。分注やその他の手動操作は、多くのサンプルを同時に扱う場合、自動化よりも一貫性が低くなる傾向があります。中∼高スループットのサンプル処理を改善し、ハンズオン時間を短縮し、高い再現性を確保するために、KingFisher FlexおよびKingFisher Duo Prime装置用のIPプロトコルを開発しました。自動化プロトコルは手動プロトコルを再現するため、同等に高い標的タンパク質収量と、同様に低い非特異的結合および高い再現性を得られます。10個のサンプルを扱うか96個のサンプルを扱うかは問題ではありません。IPプロトコルはサンプル個数に関わらず40分未満です。試薬をプレートにロードし、“Start(スタート)”ボタンを押すだけで、下流分析の準備ができたころにはIPが完了しています。使用する抗体、および標的タンパク質の存在量や特異性によっては、(インキュベーション時間などの)最適化が必要になる場合があります。

•KingFisher Duo装置を低~中スループット(1~12サンプル/ラン)に使用する
• KingFisher Flex装置をハイスループット(12~96サンプル/ラン)に使用する
自動プロトコルを見る
KingFisher Flex装置に関するビデオを見る

Dynabeadsの詳細を見る
免疫沈降選択ガイド、データ、参考文献を見る
• Dynabeads分離用マグネットを見る
他用途のDynabeads製品を探す

OEM購入
Dynabeadsヒツジ抗マウスIgGをOEMベースで購入するには、当社のライセンスおよびOEM販売部門にお問い合わせください。
研究用にのみ使用できます。診断用には使用いただけません。
仕様
認証/コンプライアンスISO9001 and ISO13485
Brown
濃度10 mg/mL
概要Polyclonal sheep anti-mouse IgG covalently bound to Dynabeads
直径(メートル法)2.8 μm
使用対象(アプリケーション)タンパク質精製
使用対象 (装置)KingFisher™ Duo Prime、KingFisher™ Flex、KingFisher™ Apex、DynaMag™マグネット
フォーマット懸濁液中のビーズ
高スループット適合性ハイスループットに対応
リガンドタイプ抗体
材料ポリスチレン
数量10 mL
反応性マウスIgG1、IgG2a、およびIgG2bを結合します。マウスIgG3およびIgMに対する低い反応性。
規制状況For Research Use Only
品質保持期間製造日から36カ月
出荷条件室温
ヒツジ
ターゲットProteins
均一性Monosized 2.8 μm (CV <5%)
タイプ抗体コーティングビーズ
Unit SizeEach
組成および保存条件
内容:10 mL Dynabeads™ M-280ヒツジ抗マウスIgG(10 mg ビーズ/mL)
保存:2~8℃

よくあるご質問(FAQ)

I am getting high background using Dynabeads M-280 Streptavidin magnetic beads. How can I prevent this from happening?

The background might be caused by nonspecific binding to the BSA on the bead surface. Alternatively, high background might be caused by nonspecific binding to streptavidin. Increasing either the pH or the salt concentration might help reduce the binding. Dynabeads M-270 Streptavidin magnetic beads might be a better alternative; these beads are not coated with BSA and are hydrophilic, as they are based upon carboxylic acid chemistry.

My Dynabeads magnetic beads are not pelleting well with the magnet. Do you have any suggestions for me?

Please review the following possibilities for why your Dynabeads magnetic beads are not pelleting:

- The solution is too viscous.
- The beads have formed aggregates because of protein-protein interaction.

Try these suggestions: - Increase separation time (leave tub on magnet for 2-5 minutes)
- Add DNase I to the lysate (~0.01 mg/mL)
- Increase the Tween 20 concentration to ~0.05% of the binding and/or washing buffer.
- Add up to 20 mM beta-merecaptoethanol to the binding and/or wash buffers.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

I have a long double-stranded DNA fragment I would like to isolate. What product do you recommend?

For biotin-labeled DNA that is less than 1 kb, we recommend you use Dynabeads M270 Streptavidin (Cat. No. 65305) and MyOne C1 magnetic beads (Cat. No. 65001). We recommend our Dynabeads KilobaseBINDER Kit (Cat. No. 60101), which is designed to immobilize long (>1 kb) double-stranded DNA molecules. The KilobaseBINDER reagent consists of M-280 Streptavidin-coupled Dynabeads magnetic beads along with a patented immobilization activator in the binding solution to bind to long, biotinylated DNA molecules for isolation. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/immobilisation-of-long-biotinylated-dna-fragments.html) for more information in regards to long biotinylated DNA fragment isolation.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

Can I use Dynabeads magnetic beads to isolate single-stranded DNA templates?

Yes, Dynabeads magnetic beads can be used to isolate single-stranded DNA. Streptavidin Dynabeads magnetic beads can be used to target biotinylated DNA fragments, followed by denaturation of the double-stranded DNA and removal of the non-biotinylated strand. The streptavidin-coupled Dynabeads magnetic beads will not inhibit any enzymatic activity. This enables further handling and manipulation of the bead-bound DNA directly on the solid phase. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/preparing-single-stranded-dna-templates.html) for more information in regards to single-stranded DNA capture.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

What is the magnetic susceptibility for Dynabeads magnetic beads?

Magnetic susceptibility is a measure of how quickly the beads will migrate to the magnet. This will depend on the iron content and the character of the iron oxide. The magnetic susceptibility given for the Dynabeads magnetic beads is the mass susceptibility, given either as cgs units/g or m^3/kg (the latter being an SI unit). For ferri- and ferromagnetic substances, the magnetic mass susceptibility is dependent upon the magnetic field strength (H), as the magnetization of such substances is not a linear function of H but approaches a saturation value with increasing field. For that reason, the magnetic mass susceptibility of the Dynabeads magnetic beads is determined by a standardized procedure under fixed conditions. The magnetic mass susceptibility given in our catalog is thus the SI unit. Conversion from Gaussian (cgs, emu) units into SI units for magnetic mass susceptibility is achieved by multiplying the Gaussian factor (emu/g or cgs/g) by 4 pi x 10^-3. The resulting unit is also called the rationalized magnetic mass susceptibility, which should be distinguished from the (SI) dimensionless magnetic susceptibility unit. In general, magnetic mass susceptibility is a measure of the force (Fz) influencing an object positioned in a nonhomogenous magnetic field. The magnetic mass susceptibility of the Dynabeads magnetic beads is measured by weighing a sample, and then subjecting the sample to a magnetic field of known strength. The weight (F1) is then measured, and compared to the weight of the sample when the magnetic field is turned off (F0). The susceptibility is then calculated as K x 10^-3 = [(F1-F0) x m x 0.335 x 10^6], where K is the mass susceptibility of the sample of mass m. The susceptibility is then converted to SI units.

Find additional tips, troubleshooting help, and resources within our Dynabeads Nucleic Acid Purification Support Center.

引用および参考文献 (11)

引用および参考文献
Abstract
Development and mechanism of ?-secretase modulators for Alzheimer's disease.
Authors:Crump CJ, Johnson DS, Li YM
Journal:Biochemistry
PubMed ID:23614767
'?-Secretase is an aspartyl intramembranal protease composed of presenilin, Nicastrin, Aph1, and Pen2 with 19 transmembrane domains. ?-Secretase cleaves the amyloid precursor proteins (APP) to release Aß peptides that likely play a causative role in the pathogenesis of Alzheimer&#39;s disease (AD). In addition, ?-secretase cleaves Notch and other type I ... More
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls.
Authors:Kvartsberg H, Portelius E, Andreasson U, Brinkmalm G, Hellwig K, Lelental N, Kornhuber J, Hansson O, Minthon L, Spitzer P, Maler JM, Zetterberg H, Blennow K, Lewczuk P
Journal:
PubMed ID:26136856
'Synaptic dysfunction and degeneration are central events in Alzheimer''s disease (AD) pathophysiology that are thought to occur early in disease progression. Synaptic pathology may be studied by examining protein biomarkers specific for different synaptic elements. We recently showed that the dendritic protein neurogranin (Ng), including the endogenous Ng peptide 48 ... More
Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
Authors:Portelius E, Lashley T, Westerlund A, Persson R, Fox NC, Blennow K, Revesz T, Zetterberg H
Journal:
PubMed ID:25591542
'Senile plaques in Alzheimer''s disease (AD) are composed of amyloid-ß (Aß), especially N-truncated forms including Aß4-42. These are thought to be neurotoxic. However, individuals may live for decades with biomarker evidence of cerebral ß-amyloidosis (positive amyloid PET imaging and/or low cerebrospinal fluid levels of the 42 amino acid form of ... More
Pyroglutamate amyloid ß (Aß) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease.
Authors:Wittnam JL, Portelius E, Zetterberg H, Gustavsson MK, Schilling S, Koch B, Demuth HU, Blennow K, Wirths O, Bayer TA
Journal:J Biol Chem
PubMed ID:22267726
'Pyroglutamate-modified Aß peptides at amino acid position three (Aß(pE3-42)) are gaining considerable attention as potential key players in the pathogenesis of Alzheimer disease (AD). Aß(pE3-42) is abundant in AD brain and has a high aggregation propensity, stability and cellular toxicity. The aim of the present work was to study the ... More
APP metabolism regulates tau proteostasis in human cerebral cortex neurons.
Authors:Moore S, Evans LD, Andersson T, Portelius E, Smith J, Dias TB, Saurat N, McGlade A, Kirwan P, Blennow K, Hardy J, Zetterberg H, Livesey FJ
Journal:
PubMed ID:25921538
'Accumulation of Aß peptide fragments of the APP protein and neurofibrillary tangles of the microtubule-associated protein tau are the cellular hallmarks of Alzheimer''s disease (AD). To investigate the relationship between APP metabolism and tau protein levels and phosphorylation, we studied human-stem-cell-derived forebrain neurons with genetic forms of AD, all of ... More